You are here
New Fixed Ratio Basal – Bolus Insulin Combination Therapy for Diabetes Specialists
for Diabetes Specialists
This course reviews the rationale for combining basal insulin and rapid-acting insulin analogues and highlights some important safety aspects of this treatment approach. It describes how control of fasting plasma glucose and postprandial glucose can be achieved with new fixed-ratio basal and rapid-acting insulin analogue combination. Guidance is provided that is intended to help you identify appropriate patients for these flexible and convenient combination.
Developed by Elsevier B.V., supported by an unrestricted educational grant from Novo Nordisk